Iron deficiency and iron deficiency anemia (IDA) represent a significant global health burden that, if left untreated, can lead to debilitating fatigue and impaired cognitive function, as well as more serious cardiac complications in some patients. As highly accessible health care professionals, pharmacists play a critical role in the identification, management, and patient counseling for IDA. This resource center on IDA contains 4 dynamic webinars designed to enhance pharmacist expertise in managing IDA, particularly its unique complexities across various patient populations. The programs delve into the specific diagnostic and treatment considerations for IDA in patients with heart failure, individuals living with inflammatory bowel disease, those undergoing cancer treatment, and women across all life stages. Each webinar provides evidence-based strategies, guideline recommendations, and practical insights such as protocols for identifying and using iron replacement to help optimize patient care and improve outcomes.

Latest Hematology news from Pharmacy Times:

An Overview of Intravenous Iron in Heart Failure and the FAIR-HF2 Trial

Learn More >

Study Findings Suggest Addressing Maternal Anemia Could Reduce Risk of Congenital Heart Disease in Infants

Learn More >

ACC 2025: Intravenous Iron Safe, but Results in Mixed Findings for Patients With Heart Failure

Learn More >

Early Intervention With IV Iron Is Safe, Effective for Anemia During Pregnancy

Learn More > 

Product Updates for October 2025

Learn More >

Pharmacists Are Crucial Partners in Guiding Nutrition and Supplement Use With GLP-1s

Learn More >

How to Educate Patients About Safety, Regulation, and Quality of Vitamins and Supplements

Learn More >

Pharmacist Strategies for Navigating Supplement Use in Patients on TNF Inhibitors

Learn More >